Dyspnea, or breathlessness, is a common symptom encountered in clinical practice. Its subjective nature and multifactorial etiology can make it a challenging symptom to evaluate and manage. This article aims to provide a comprehensive clinical approach to dyspnea, focusing on assessment, differential diagnosis, and management strategies.
Initial evaluation of dyspnea should involve a detailed history and physical examination. Important factors to consider include onset, duration, severity, precipitating factors, and associated symptoms. Objective measures such as pulse oximetry, spirometry, and peak flow rate can provide useful information about the patient’s respiratory status.
The differential diagnosis for dyspnea is broad and includes cardiac, pulmonary, and non-physiological causes. Cardiac causes include heart failure and ischemic heart disease. Pulmonary causes include chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and pulmonary embolism. Non-physiological causes include anxiety and deconditioning. Careful consideration of the patient’s history, physical examination, and diagnostic testing can help narrow the differential diagnosis.
Management of dyspnea should be tailored to the underlying cause. For cardiac causes, management may involve medications, lifestyle modifications, and potentially invasive procedures. Pulmonary causes may require bronchodilators, corticosteroids, antibiotics, or anticoagulants, depending on the specific diagnosis. Non-physiological causes may benefit from behavioral therapies, physical rehabilitation, or treatment of underlying psychiatric conditions.
Dyspnea is a common but complex symptom that requires a systematic and thorough clinical approach. By understanding the potential etiologies of dyspnea and utilizing a methodical approach to assessment and management, healthcare professionals can effectively diagnose and treat this distressing symptom, improving patient outcomes and quality of life.
1.
Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.
2.
A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.
3.
New imaging guidelines for head and neck cancers, a step toward practice change
4.
How wildfires pose challenges to cancer care
5.
Annual whole-body, low-dose CT aids management of smoldering multiple myeloma
1.
Checkpoint Inhibitors in Oncology: Advances in PD-1/PD-L1 and CTLA-4 Targeted Therapy
2.
Mitoxantrone–Napabucasin Co-Nanoformulation Activates cGAS-STING in HCC Therapy
3.
Geriatric Medicine Through Long-Term Functional Survivorship After Cancer in Older Adults
4.
Omentum Cancer: Causes, Symptoms, and Treatment Options
5.
Advanced Directions in Oncology and Quality Improvement
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
When Unexplained Bruising May Require Blood Testing
2.
Current Scenario of Cancer- The Incidence of Cancer in Men
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
4.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation